CLINICAL_TRIALS
trial_result
· 2022-01-11
Clinical Trial Update: Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year [Phase 3]
Summary
A Phase 3 trial compares the safety and efficacy of adalimumab versus ustekinumab over one year in Crohn's disease; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Scientific Affairs, LLC | Conditions: Crohn Disease | Phase 3 | Status: COMPLETED | Results posted: 2022-01-11